Søren Tulstrup
Chief Executive Officer at HANSA BIOPHARMA AB
Net worth: 85 839 $ as of 2024-03-30
Network origin in Søren Tulstrup first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 27 | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA.
16
| Subsidiary | Medical Specialties | 16 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA
9
| Subsidiary | Pharmaceuticals: Major | 9 |
| Extinct | Pharmaceuticals: Major | 6 | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Søren Tulstrup via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal Sales & Marketing | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Corporate Secretary Treasurer | |
| AGENUS INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| IPSEN | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
| SOLENO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| TRANSLATE BIO, INC. | Biotechnology | Founder Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
ArmaGen, Inc.
 ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA. | Hospital/Nursing Management | Director/Board Member Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
| UCB | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| ACTIVE BIOTECH AB | Biotechnology | Director of Finance/CFO General Counsel | |
| George Washington University | College/University | Undergraduate Degree Masters Business Admin | |
Shire US, Inc.
 Shire US, Inc. Medical DistributorsDistribution Services Shire US, Inc. sells and markets prescription medicines. The company was founded on September 28, 1983 and is headquartered in Lexington, MA. | Medical Distributors | Chief Tech/Sci/R&D Officer Director/Board Member | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| Tufts University | College/University | Doctorate Degree Doctorate Degree | |
| University of Bristol | College/University | Undergraduate Degree Doctorate Degree | |
| University of Uppsala | College/University | Graduate Degree Corporate Officer/Principal Graduate Degree | |
Envirotainer AB
 Envirotainer AB Containers/PackagingProcess Industries Envirotainer AB provides cold chain solutions for the pharmaceutical supply chain. It offers active cold chain services, qualification services, shipment set up services, technical support, post-shipment analysis and telemetry solution. The company was founded in 1985 and is headquartered in Sollentuna, Sweden. | Containers/Packaging | Director/Board Member Corporate Officer/Principal | |
| WEIFA ASA | Pharmaceuticals: Major | Chairman Director/Board Member | |
| University of Lund | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree Graduate Degree Undergraduate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree | |
| Swiss Federal Institute of Technology | College/University | Graduate Degree Doctorate Degree | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Genzyme Europe BV
 Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The private company is based in Amsterdam, Netherlands. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree | |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member Human Resources Officer | |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Nexttobe AB
 Nexttobe AB Investment ManagersFinance Nexttobe AB focuses on growth equity investments in healthcare, medical devices, and specialty pharmaceutical companies. It is a venture capital/private equity firm that invests in technology and consumer companies. The company was founded by Bengt Ågerup in 2011 and is headquartered in Uppsala, Sweden. | Investment Managers | Chairman Chief Tech/Sci/R&D Officer | |
Vifor Fresenius Medical Care Renal Pharma Ltd.
 Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Vifor Fresenius Medical Care Renal Pharma Ltd. engages in the research in as well as development, marketing, and distribution of pharmaceutical products used in the field of nephrology for the treatment of patients suffering from chronic kidney disease. It offers products specialized in anemia, mineral, bone, and cardio-renal management. The company was founded on November 26, 2010 and is headquartered in St. Gallen, Switzerland. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Avillion LLP
 Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member Corporate Officer/Principal | |
| The Fuqua School of Business | College/University | Masters Business Admin Masters Business Admin | |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Chairman Chief Executive Officer | |
X-Vax Technology, Inc.
 X-Vax Technology, Inc. BiotechnologyHealth Technology X-Vax Technology, Inc. operates as a biotechnology company. The company was founded in 2015 and is headquartered in New York, NY. | Biotechnology | Chief Executive Officer Chief Operating Officer | |
| GALENICA AG | Medical Distributors | Director/Board Member Director/Board Member | |
| DEVONIAN HEALTH GROUP INC. | Pharmaceuticals: Major | Director/Board Member Chairman |
Statistics
International
| United States | 23 |
| Sweden | 9 |
| Switzerland | 7 |
| Denmark | 4 |
| Belgium | 4 |
Sectoral
| Health Technology | 34 |
| Consumer Services | 11 |
| Distribution Services | 3 |
| Health Services | 2 |
| Process Industries | 2 |
Operational
| Director/Board Member | 218 |
| Corporate Officer/Principal | 163 |
| Chairman | 70 |
| Independent Dir/Board Member | 65 |
| Chief Executive Officer | 54 |
Most connected contacts
| Insiders | |
|---|---|
| Claus Asbjørn Andersson | 41 |
| Marc M. P. de Garidel | 31 |
| Folke Per-Olof Wallström | 30 |
| Eva Nilsagård | 30 |
| Ulf Arne Wiinberg | 26 |
| Sylvie Grégoire | 25 |
| Colin Bond | 25 |
| Anders Gersel Pedersen | 24 |
| Johannes G. C. P. Schikan | 22 |
| Gwen Melincoff | 20 |
| Romeo Cerutti | 18 |
| Frédéric Chéreau | 17 |
| Kathryn Gregory | 16 |
| Keith Graham McCullagh | 16 |
| Howard Mayer | 16 |
- Stock Market
- Insiders
- Søren Tulstrup
- Company connections
